Search

TRICALS aims to improve clinical research to finding a cure for ALS. We are conducting a survey among industry partners to assess how the design and operational aspects can be optimized, thereby making clinical trials in ALS more efficient, more cost-effective, and of higher quality.

One year ago TRICALS launched the educational platform ‘The TRICALS Academy’.

Last month marked a significant moment for the TRICALS Academy, as the first live training of the newly developed ‘electrophysiological assessments’ course took place. ALS professionals from all over the world gathered in the UMC Utrecht, to learn the ins and outs of assessing motor functioning.

The Lighthouse II study finished recruiting. With currently 419 participants in the study, the study exceeded their goal of including 390 participants with ALS.

In the reALiSe study the safety and efficacy of the drug ARGX-119 for the treatment of ALS is investigated.

Step by step we tell you what to expect about participating in a clinical trial.